Novozymes 9M 2016 Earnings Conference Call

Novozymes reported 9M 2016 results with 1% organic sales growth driven by Household Care, F&B, and Technical & Pharma segments, while Bioenergy and BioAg remained challenged. EBIT margin held steady at 27.7%, with company highlighting acquisition of Organo Balance and sustainability achievements.